Medical Conditions, Family History of Cancer, and the Risk of Biliary Tract Cancers

2016 ◽  
Vol 102 (3) ◽  
pp. 252-257 ◽  
Author(s):  
Valentina Rosato ◽  
Cristina Bosetti ◽  
Dal Luigino Maso ◽  
Maurizio Montella ◽  
Diego Serraino ◽  
...  
2018 ◽  
Vol 27 (3) ◽  
pp. 348-351 ◽  
Author(s):  
Alison L. Van Dyke ◽  
Margaret S. Langhamer ◽  
Bin Zhu ◽  
Ruth M. Pfeiffer ◽  
Demetrius Albanes ◽  
...  

BMC Cancer ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Loredana Radoï ◽  
Sophie Paget-Bailly ◽  
Florence Guida ◽  
Diane Cyr ◽  
Gwenn Menvielle ◽  
...  

Author(s):  
Alexander L. R. Grewcock ◽  
Karlijn E. P. E. Hermans ◽  
Matty P. Weijenberg ◽  
Piet A. Brandt ◽  
Caroline Loef ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 631
Author(s):  
Karin Alvarez ◽  
Alessandra Cassana ◽  
Marjorie De La Fuente ◽  
Tamara Canales ◽  
Mario Abedrapo ◽  
...  

Colorectal cancer (CRC) is the second most frequent neoplasm in Chile and its mortality rate is rising in all ages. However, studies characterizing CRC according to the age of onset are still lacking. This study aimed to identify clinical, pathological, and molecular features of CRC in Chilean patients according to the age of diagnosis: early- (≤50 years; EOCRC), intermediate- (51–69 years; IOCRC), and late-onset (≥70 years; LOCRC). The study included 426 CRC patients from Clinica Las Condes, between 2007 and 2019. A chi-square test was applied to explore associations between age of onset and clinicopathological characteristics. Body Mass Index (BMI) differences according to age of diagnosis was evaluated through t-test. Overall (OS) and cancer-specific survival (CSS) were estimated by the Kaplan–Meier method. We found significant differences between the age of onset, and gender, BMI, family history of cancer, TNM Classification of Malignant Tumors stage, OS, and CSS. EOCRC category was characterized by a family history of cancer, left-sided tumors with a more advanced stage of the disease but better survival at 10 years, and lower microsatellite instability (MSI), with predominant germline mutations. IOCRC has shown clinical similarities with the EOCRC and molecular similarities to the LOCRC, which agrees with other reports.


Cancer ◽  
2008 ◽  
Vol 112 (2) ◽  
pp. 399-406 ◽  
Author(s):  
Heather Orom ◽  
Michele L. Coté ◽  
Hector M. González ◽  
Willie Underwood ◽  
Ann G. Schwartz

2016 ◽  
Vol 26 (4) ◽  
pp. 806-813 ◽  
Author(s):  
Aimee L. Lucas ◽  
Adam Tarlecki ◽  
Kellie Van Beck ◽  
Casey Lipton ◽  
Arindam RoyChoudhury ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document